Inoko Vision (formerly AM2M R&D Company) builds NeuroFET - a unique, non-invasive optical device for measuring eye movement as an objective biomarker of the neurological state of the brain. Our patent pending technology enables early screening against Alzheimer disease and regular brain monitoring. Inoko Vision is a spin-off from Nicolaus Copernicus University employing scientists and engineers developing novel methods of biomedical imaging.